ProQR Therapeutics

ProQR is a biotechnology company dedicated to changing lives by developing RNA therapies for severe rare and common diseases

Biotech & Life Sciences

Sector

Seed

Stage

Biotechnology

Model

01Company Overview

ProQR is a biotechnology company dedicated to changing lives by developing RNA therapies for severe rare and common diseases. The company focuses on advancing its proprietary Axiomer™ RNA-editing platform technology.

02Backed By1 investor

SPSofinnova Partners→

03Recent Activity

Is this your company? Claim your profile

FROM Sofinnova Partners

Portfolio company ProQR appointed Chris Hart as Chief Data and AI Officer and Thomas Wolf to its Board as Strategic AI Advisor.

MILESTONE·sofinnovapartners.com

SEP 23, 2026

04Similar Companies

A

AIRNA

Biotech & Life Sciences

→

KB

Korro Bio

Biotech & Life Sciences

→

AT

Addition Therapeutics

Biotech & Life Sciences

→

WL

Wave Life Sciences

Biotech & Life Sciences

→

IM

Iris Medicine

Biotech & Life Sciences

→

05Startup DNA

8

signals

Sectors
Business Model
Technology